| Utrogestan (progesterone) / Besins Healthcare |
2008-002689-68: Comparing different ways of preparing patients for frozen-thawed embryo transfer Onderzoek naar verschillende wijzen van voorbereiding op het terugplaatsen van gecryopreserveerde embryo’s. |
|
|
| Ongoing | 4 | 1150 | Europe | progynova, utrogestan, RVG 05311., RVG 11473, Tablet, progynova | Isala Klinieken, location Sophia, MSD | Subfertility in need of IVF and IVF-ICSI treatment., Subfertility in need of IVF and IVF-ICSI treatment., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2005-001016-51: In vivo effects of transdermal Estradiol+ oral Progesterone vs oral Conjugated Equine Estrogens + MedroxyProgesteroneAcetate on normal human breast cells proliferation: a randomized comparative study |
|
|
| Ongoing | 4 | 80 | Europe | Utrogestan, Oestrogel, Premelle Cycle, Utrogestan, Oestrogel, Premelle Cycle, Utrogestan, Oestrogel, Premelle Cycle | Karolinska Hospital | Menopausal symptoms | | | | |
2011-003250-34: Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays. Receptividad endometrial con diferentes protocolos de soporte de fase lútea en ciclos de estimulación ovárica en los que la maduración final ovocitaria se realiza con análogos de la GnRH. Análisis mediante microarrays de endometrio. |
|
|
| Ongoing | 4 | 25 | Europe | Progynova, UTROGESTAN, Luveris, Ovitrelle, Progynova, UTROGESTAN, Luveris, Ovitrelle | IVI Madrid, Merck Sharp & Dohme de España, SA | Ovarian Hyperstimulation Syndrome (OHSS) Síndrome de Hiperestimulación Ovárica (SHO) | | | | |
2012-004511-30: A randomised controlled trial to compare the effect of 2 progesterones on the vascular elasticity, lipid profiles and coagulation cascade (clotting factors) of women with premature ovarian failure. |
|
|
| Ongoing | 4 | 90 | Europe | Utrogestan, Provera Tablets, Utrogestan, Provera Tablets | King\'s College Hospital NHS Foundation Trust, King's College Hospital NHS Foundation Trust | Premature ovarian failure. | | | | |
ChiCTR-OIN-16008529: The clinical outcome of MPA and Duphaston and Utrogestan in Primed-progesterone ovarian stimulation protocol for advanced endometriosis patients undergoing IVF cycle |
|
|
| Recruiting | 4 | 450 | | HMG+MPA ;HMG+Duphaston ;HMG+Utrogestan | The Shanghai Ninth People's Hospital affiliated of Shanghai JiaoTong University of medical school; Shanghai Nineth People's Hospital, the Natural Science Foundation of Shanghai | infertility | | | | |
2018-000689-13: Pregnancy rate with 1 week versus 2 weeks of hormonal therapy |
|
|
| Not yet recruiting | 4 | 150 | Europe | progynova, utrogestan, RVG 05311., RVG 11473, Tablet, Capsule, progynova, utrogestan | University hospital Brussel, University hospital Brussel | Subfertility in need of IVF and IVF-ICSI treatment, Subfertility in need of IVF and IVF-ICSI treatment, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
ChiCTR-IPR-17012998: The clinical outcomes of MPA and Duphaston and Utrogestan in Primed-progesterone ovarian stimulation protocol for patients with polycystic ovarian syndrome undergoing IVF cycle |
|
|
| Recruiting | 4 | 390 | | HMG+MPA ;HMG+Duphaston ;HMG+Utrogestan | Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine; None, the Natural Science Foundation of Shanghai | infertility | | | | |
2018-000105-23: Support of the implantation of the embryo after transferring to the uterus in IVF/ICSI: a comparison between taking progesterone by mouth or vaginal. |
|
|
| Not yet recruiting | 4 | 30 | Europe | Film-coated tablet, Vaginal capsule, soft, Duphaston 10, filmomhulde tabletten 10 mg, Utrogestan | UZ Brussel, UZ Brussel | Female infertility, Female inability to conceive a child, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
2020-004491-17: Oral versus vaginal progesterone for luteal phase support in frozen embryo transfer cycles. |
|
|
| Not yet recruiting | 4 | 150 | Europe | Tablet, Capsule, soft, Duphaston 10 mg, Utrogestan Vaginal 200 mg | UZ Brussel, Abbott | progesterone as luteal phase supplementation in frozen embryo transfer cycles, frozen embryo transfer cycles for infertility treatment, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
2021-000941-42: INTEnsity of ovariaN Stimulation and Embryo Quality Intensidad de la estimulación ovárica y calidad embrionaria |
|
|
| Ongoing | 4 | 100 | Europe | Solution for injection in pre-filled pen, Solution for injection, Capsule, soft, , Ovaleap 900 UI/1,5 ml solucion inyectable, Ovaleap 450 UI/0,75 ml solucion inyectable, Ovaleap 300 UI/0,5 ml solucion inyectable, Orgalutran 0,25 mg/0,5 ml solución inyectable, Ovitrelle 250 microgramos solución inyectable en pluma precargada., Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, utrogestan 200 mg cápsulas blandas, Omifin 50 mg comprimidos | Fundacion Santiago Dexeus Font, Fundación Santiago Dexeus Font | To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder approach ( Clomiphene Citrate (CC) 50mg/day plus 150IU daily dose of rFSH) and a more intense approach (300IU daily dose of rFSH). Comparar el número de embriones buena calidad y los parámetros morfocinéticos de desarrollo temprano de embriones en pacientes infértiles subóptimas sometidas a dos intensidades de estimulación ovárica diferentes, una más suave (Citrato de Clomifeno más 150 UI FSHr diariamente) y una mas intensa (300 UI FSHr diariamente), To compare the two stimulation groups of Clomiphene Citrate (CC) 50mg/day plus rFSH 150IU vs. 300IU regarding the number of good quality blastocysts (GQB) in suboptimal patients. Comparar los dos grupos de estimulación de Citrato de Clomifeno más 150 UI FSHr vs. 300UI FSHr en cuanto al número de blastocistos de buena calidad en pacientes subóptimas, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT04797338: Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders |
|
|
| Recruiting | 4 | 100 | RoW | Synarel, 0.2 Mg/Inh Nasal Spray, Nafarelin, Estrofem, Progynova, Utrogestan, Endometrin, Hydroxyprogesterone Caproate, Proluton Depot | Assaf-Harofeh Medical Center | Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome | 09/21 | 09/21 | | |
NCT02430233: Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor |
|
|
| Completed | 4 | 129 | RoW | micronized progesterone 400 mg (Utrogestan), Utrogestan- 200mg×2 PV(per vagina) per day | HaEmek Medical Center, Israel | Preterm Labor | 02/23 | 02/23 | | |
ChiCTR2100053693: Randomized Controlled Trial of Allylestrenol Tablets in the Prevention of Late Abortion / Preterm Birth |
|
|
| Not yet recruiting | 4 | 296 | | Allylestrenol Tablets ;Progesterone Soft Capsules (Utrogestan) | Shengjing Hospital of China Medical University; Changzhou Siyao Pharmaceuticals Co., Ltd., Changzhou Siyao Pharmaceuticals Co., Ltd. | late abortion, preterm birth | | | | |
LUMO, NCT05080569: Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment |
|
|
| Not yet recruiting | 4 | 1008 | NA | Progesterone Vaginal Product, Utrogestan, Placebo | UMC Utrecht | Pregnancy Related, Fertility Issues, Luteal Phase Defect, Infertility Unexplained | 07/25 | 08/26 | | |
| Active, not recruiting | 4 | 362 | Europe | Estradiol Valerate, Progynova, Micronized progesterone, Utrogestan | CRG UZ Brussel | Miscarriage, Frozen Embryo Transfer, Natural Cycle, Hormone Replacement Therapy Cycle, Preimplantation Genetic Screening, Euploid Embryos | 09/25 | 12/25 | | |
2007-007950-77: Förebyggande behandling med progesteron för att förhindra förtidsbörd |
|
|
| Ongoing | 3 | 1250 | Europe | Capsule, soft, Utrogestan | University of Edinburgh and NHS Lothian Health Board, MRC, Besins Healthcare, Hologic | Preterm labour, Förtidsbörd, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2014-002348-42: Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial) |
|
|
| Ongoing | 3 | 4150 | Europe | Progesterone 200mg capsules, Capsule, Utrogestan 200mg capsules | University of Birmingham, National Institute for Health Research | Vaginal bleeding in the first 12 weeks of pregnancy., Vaginal bleeding in the first 12 weeks of pregnancy., Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
2008-005987-15: Preventing preterm birth: Costs and effects of screening of healthy women with a singleton pregnancy for a short cervical length. |
|
|
| Ongoing | 3 | 1920 | Europe | Utrogestan, Utrogestan | AMC Amsterdam | Preterm birth with healthy singleton pregnancies | | | | |
2009-011208-42: First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: A randomised, double-blind, placebo-controlled, multi-centre trial [The PROMISE (PROgesterone in recurrent MIScarriagE) Trial] Funded by NIHR-HTA(UK) 08/38/01 for £1.2million |
|
|
| Ongoing | 3 | 670 | Europe | UTROGESTAN 200mg CAPSULES, UTROGESTAN 200mg CAPSULES, UTROGESTAN 200mg CAPSULES | Imperial College, London, Academic Medical Center Amsterdam | Recurrent Miscarriage | | | | |
2013-002884-24: Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length Pessarium of progesteron ter reventie van vroeggeboorte in vrouwen met een korte cervixlengte |
|
|
| Ongoing | 3 | 960 | Europe | Capsule, soft, Utrogestan | AMC, AMC Amsterdam | preterm birth vroeggeboorte, preterm birth vroeggeboorte, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
2021-001624-17: Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone therapy – a double-blind randomized study- PROBES study (Progesterone Breast Endometrial Safety study) Säkerhet med oralt mikroniserat progesteron jämfört med noretisteronacetat i kontinuerlig kombination med oralt östrogen som menopausal hormonbehandling - en dubbelblind randomiserad studie- PROBES-studien |
|
|
| Ongoing | 3 | 520 | Europe | Micronized progesterone, Activelle, Estrofem, Capsule, Utrogestan, Activelle, Estrofem | Karolinska University Hospital, Karolinska University Hospital | Climacteric symptoms, Climacteric symptoms, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT04342585: Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical Length |
|
|
| Completed | 3 | 142 | RoW | Micronised vaginal progesterone, Utrogestan, Vaginal pessary, Arabin pessary | National University of Malaysia | Preterm Birth | 09/22 | 09/22 | | |
2022-001045-21: MIcronized PROgesterone in Frozen embryo transfercycles Progesterona micronizada en ciclos con transferencia de embriones congelados |
|
|
| Not yet recruiting | 3 | 1020 | Europe | PROGESTERONE 400, Utrogestan 200, UTROGESTAN 300, Estrogel, Capsule, soft, , Transdermal gel, LUGESTERON 400, utrogestan 200 mg cápsulas blandas, Utrogestan 300, Estrogel® Estradiol Besins 0,75 mg/dose, gel transdermique | FUNDACION SANTIAGO DEXEUS FONT, BESINS HEALTHCARE LTD | Infertility Infertillidad, Infertility Infertillidad, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2009-017144-14: Effets du traitement hormonal substitutif et du raloxifène sur les cellules dendritiques plasmacytoïdes et les lymphocytes B chez les femmes ménopausées |
|
|
| Ongoing | 2 | 60 | Europe | E2, progestérone, Raloxifène, E2/THM, progesterone/THM, SERM, ESTRAPATCH, UTROGESTAN, OPTRUMA, ESTRAPATCH, UTROGESTAN, OPTRUMA | Centre Hospitalier de Toulouse | Menopause | | | | |
2017-001521-41: A window of opportunity study to assess the biological effects of progesterone in premenopausal ER-positive, PgR-positive early breast cancer |
|
|
| Not yet recruiting | 2 | 112 | Europe | UTROGESTAN, Tamoxifen, SUB04672MIG, Capsule, Tablet, UTROGESTAN, Tamoxifen | University of Liverpool, Cancer Research UK: Clinical Trials Awards and Advisory Committee (CTAAC) | Premenopausal ER-positive, PgR-positive early breast cancer, Early breast cancer that is oestrogen receptor positive and progesterone receptor positive, in patients that are premenopausal., Diseases [C] - Cancer [C04] | | | | |
2020-001952-16: Does progesterone treatment of trans women lead to increased breast development and are there side effects? A pilot trial. |
|
|
| Ongoing | 2 | 90 | Europe | Capsule, Utrogestan | Amsterdam UMC, location VUmc, Besins Healthcare | Hormone treatment of transgender women, we will investigate whether addition of progesterone to estradiol treatment results in an increase of breast volume and if there are side effects., Hormone treatment of transgender women. We will investigate whether addition of progesterone to estradiol treatment results in an increase of breast volume and if there are side effects., Body processes [G] - Physiological processes [G07] | | | | |
NCT05091866: Natural Progesterone for the Treatment of Recurrent Glioblastoma |
|
|
| Recruiting | 1 | 32 | US | Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Therapeutic Progesterone, Corlutina, Corluvite, Corpus luteum hormone, Cyclogest, Gestiron, Gestone, Lipo-Lutin, Luteohormone, Lutocyclin, Lutocylin M, Lutogyl, Lutromone, Progestasert, Progesterone, Progestin, Progestogel, Progestol, Progeston, Prolidon, Proluton, Syngesterone, Utrogestan | Emory University, National Cancer Institute (NCI) | Gliosarcoma, Recurrent Glioblastoma | 08/25 | 08/26 | | |
ChiCTR-OOC-14005277: The clinical outcome of different doses of vagina progesterone (Utrogestan) used for ovarian stimulation in normalovulatory women: a prospective, randomized, controlled trial |
|
|
| Recruiting | N/A | 150 | | Utrogestan 200mg/d ;Utrogestan 100mg/d | Shanghai Ninth People's Hospital; Shanghai Ninth People's Hospital, self-fund | infertility | | | | |
ChiCTR-IOR-15006633: The clinical outcome of controlled ovarian stimulation using Utrogestan and HMG in women with PCOS: a prospective, randomized, controlled trial |
|
|
| Not yet recruiting | N/A | 120 | | Utrogestan protocol ;Antagonist protocol | Shanghai Ninth People's Hospital; Shanghai Ninth People's Hospital, NO | infertility | | | | |
ChiCTR-IOR-16009349: Comparison of the clinical outcomes for normalovulatory patients undergoing IVF procedure using mid-late follicular phase stimulation vs. Utrogestan protocol |
|
|
| Not yet recruiting | N/A | 300 | | HMG ;Utrogestan and HMG | Shanghai Ninth Peoples Hospital; Shanghai Ninth Peoples Hospital, National nature science foundation of China | infertility | | | | |
ChiCTR-IOR-15007265: To compare the effect of Utrogestan and Duphaston in normalovulatory women undergoing IVF in the follicular primed-progesterone ovarian stimulation protocol |
|
|
| Recruiting | N/A | 250 | | Utrogestan; Duphaston | Shanghai Ninth Peoples Hospital; None, No | infertility | | | | |
ChiCTR-IOR-15007165: The clinical outcome of adding low-dose hCG in early-follicular phase in women with PCOS undergoing controlled ovarian stimulation using Utrogestan andHMG protocol: a prospective, randomized, controlled trial |
|
|
| Recruiting | N/A | 40 | | Utrogestan andHMG protocol without hCG ;Adding hCG from early-follicular phase in Utrogestan andHMG protocol | Shanghai Ninth Peoples Hospital; Shanghai Ninth Peoples Hospital, No | infertility | | | | |
Prog_STIM, NCT04108039: Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. |
|
|
| Completed | N/A | 44 | Europe | GnRh antagonist, Cetrorelix or Ganirelix, Micronized progesterone, Utrogestan | Institut Universitari Dexeus | Infertility, IVF, Preimplantation Diagnosis | 01/22 | 05/22 | | |
| Active, not recruiting | N/A | 150 | RoW | GnRH agonist, Synarel, Progesterone, Utrogestan | Shaare Zedek Medical Center | Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles | 04/22 | 01/23 | | |
DECLARED-CT, NCT06715514: Effects of Menopausal Hormone and GLP-1 Agonist Therapy on Glucose and Energy Homeostasis in Postmenopausal Women |
|
|
| Not yet recruiting | N/A | 96 | Europe | GLP-1 Receptor Agonist, Semaglutide, Wegovy, Menopausal Hormone Therapy, Oestrogel and Utrogestan | Lia Bally | Menopause, Type 2 Diabetes | 04/26 | 04/26 | | |
NCT03637062: Verify the Safety and Effectiveness of the Cerclage Pessary in Prevention and Treatment of High-risk Preterm Pregnancy |
|
|
| Not yet recruiting | N/A | 300 | NA | Progesterone, Utrogestan, pessary | QH Medical Technology Ltd. | High Risk Pregnancy | 12/26 | 12/26 | | |
NCT05089383: Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles |
|
|
| Recruiting | N/A | 698 | Europe | Utrogestan, PROLUTEX,VASCLOR | University of Athens, Iaso Maternity Hospital, Athens, Greece | Luteal Phase | 02/23 | 12/23 | | |
